Evaluation Question Matrix

Att 5_NBCCEDP Evaluation Question Matrix.docx

National Breast and Cervical Cancer Early Detection Program (NBCCEDP) Monitoring Activities

Evaluation Question Matrix

OMB: 0920-1046

Document [docx]
Download: docx | pdf

Attachment 5: NBCCEDP Evaluation Question Matrix

Evaluation Question

Clinic Data

Survey

Clinic-Level Screening Rate Changes

  1. What are trends in B/C screening rates over time across health system clinics?

  • What are baseline B/C screening rates in clinics?

  • Are clinics’ screening rates increasing over time?

  • Are clinics meeting targets for B/C screening?

X


  1. What are the characteristics of the health systems and clinics where EBIs are being implemented?

  • What are the characteristics of the health systems and their clinics that both deliver NBCCEDP screening services and implement EBIs?

X


Patient Reach / Patient Demographics and Eligibility Criteria

  1. What is the reach of the B/C screening program via health systems and their clinics?

  • How many health systems and their clinics are grantees partnering with for health systems change?

  • How many women within the age-eligible group for screening are served by these clinics?

  • How many providers work at these clinics?

  • What is the geographic location of health system clinics?

X


EBIs to Support B&C Screening

  1. What EBIs are grantees implementing and/or enhancing within health system clinics?

  • Are B/C resources used to support EBI implementation?

  • What EBIs are being implemented with B/C resources?

  • Are multiple EBIs being implemented within clinics? If so, which combinations are used?

X


  1. What EBIs (or combination of EBIs) are associated with greater increases in B/C screening within health system clinics?

X


  1. To what extent is implementation of the EBIs sustainable1 without NBCCEDP funding?

X


Partnerships to Support Screening

  1. What are the characteristics of grantees’ screening provider sites delivering B/C clinical services?

  • How many and what types of screening provider sites comprise the NBCCEDP screening provider network?

  • How much funding is budgeted to support B/C clinical services?


X

  1. What are the characteristics of the non-health system/clinic partners that grantees engage to support the B/C program?

  • What types and how many non-health system/clinic partners do grantees engage to support the program?

  • Are partnerships already established or newly formed?

  • Are partnerships formalized (e.g., MOU, contract)?

  • How much funding is budgeted to support these partnerships?

  • What types of activities do these partners conduct?


X

Community Outreach and Patient Navigation

  1. To what extent are health systems and their clinics utilizing community health workers to reach priority?

  • How many CHWs are funded through the NBCCEDP?

  • What types of community outreach activities are conducted to support community-clinical linkages?2

X

X

  1. To what extent are health systems and their clinics utilizing patient navigators to support priority populations?

  • How many women were served through patient navigation (including those who did and did not receive screening services at B/C provider sites)?

  • How many women receive patient navigation at partner health system clinic sites where EBIs are delivered

  • What patient navigation activities were delivered to patients?

X

X

Support of Healthy Lifestyle Behaviors

  1. Do health system clinic partners have a comprehensive B/C screening policy in place?

X


Grantee Infrastructure (Including Health IT)

  1. Are clinic data monitored for quality?

  • What is clinics’ confidence in screening rates generated by EHRs?

  • Do health systems validate their screening rates?

  • What are the known data issues?

  • What improvements have been made to EHR systems?

X

X

  1. What types of health IT support are grantees providing to health systems?


X

Grantees’ Monitoring and Evaluation

  1. What monitoring and evaluation activities are grantees implementing?

  • Are grantees using data to inform programmatic decision-making and/or clinic-level service delivery?

  • What types of data are used by grantees?

  • How often are data used?

  • Are grantees using data dashboards to inform decision-making? If so, what decisions are influenced by data dashboards?

  • How frequently are grantees monitoring screening rates at clinics?

X

X

  1. What metrics, if any, are used to track programmatic progress over time?


X

Program Management

  1. What barriers and facilitators do grantees encounter when managing, implementing, and/or evaluating their programs?


X

  1. What are grantees’ technical assistance and training needs?


X

  1. What non-CDC financial resources do grantees have to support the NBCCEDP?


X

Incidence, Mortality, and Disparities

  1. Are grantees tracking incidence and/or mortality rates for priority populations?


X

  1. Are grantees tracking disparities for priority populations?


X



1 Definition of sustainability: High quality implementation that has been achieved and a supporting infrastructure is in place along with any financial support needed to maintain the intervention. The intervention has become an institutionalized component of the health system and/or clinic operations.

2 For the purposes of this FOA, community-clinical linkages are defined as interventions that coordinate services among health systems, communities, and public health organizations to facilitate access to clinical care and promote health behaviors.

File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorSchlueter, Dara (CDC/ONDIEH/NCCDPHP)
File Modified0000-00-00
File Created2021-01-20

© 2024 OMB.report | Privacy Policy